Agenus (AGEN) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. DRS
4. GS
5. BAC
6. ORCL
7. AVAV
8. ACI
9. UNH
10. SPY

Go back to Agenus (AGEN) Misses Q4 EPS by 1c

Agenus Reports Fourth Quarter and Full Year 2015 Financial and Operational Results and Recent Highlights

March 3, 2016 7:01 AM EST

Company to host conference call at 11am ET today

LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company developing checkpoint modulator antibodies and cancer vaccines, today provided a corporate update and reported financial results for the fourth quarter and year ended December 31, 2015.

During the course of 2015, we broadened our capabilities and advanced our portfolio of checkpoint antibodies and diversified vaccine platforms, commented Garo H. Armen, Ph.D., Chairman and CEO of Agenus. We made a series of strategic acquisitions, in our efforts to speed... More